University of Glasgow
Also known as: Beaston Oncology Centre, Glasgow, UK | Beatson Institute for Cancer Research - Glasgow | Beatson Institute for Cancer Research, Glasgow | Beatson Institute, University of Glasgow, Garscrube Estate, Switchback Rd. Glasgow, UK, G61 1BD | Beatson Oncology Centre | Beatson West of Scotland Cancer Centre | Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow G12 0YN | Beatson West of Scotland Cancer Centre, Glasgow | CRUK Trials unit Glasgow | Dermatology Department, Stirling Community Hospital, NHS Forth Valley, United Kingdom | Euan J Cameron | Gartnavel General Hospital | Glasgow Royal Infirmary | Glasgow University and NHS GGC | Glasgow Western Infirmary | Golden Jubilee National Hospital, NHS Scotland | Greater Glasgow and Clyde NHS Foundation Trust | Human Nutrition School of Medicine, Dentistry and Nursing, University of Glasgow | Judith Dixon-Hughes | Lynn McMahon | National Health Service: Golden Jubilee National Hospital | NHS GGC | NHS GGC and Glasgow University | NHS Greater Clyde and Glasgow | NHS Greater Glasgow and Clyde | NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital , Glasgow, United Kingdom | NHS Greater Glasgow & Clyde, Scotland | NHS Greater Glasgow Yorkhill Division | Professor Naveed Sattar | Queen Elizabeth University Hospital, Glasgow | Royal Hospital for Children Glasgow | Royal Hospital for Children, U. of Glasgow | Royal Infirmary Glaskow | Sonia Allam | Southern General Hospital, Glasgow | South Glasgow NHS Hospitals | South Glasgow University Hospitals NHS Trust | Stirling Community Hospital | The University of Glasgow | Univeristy of Glasgow | University of Glasgow | University of Glasgow and NHS Greater Glasgow and Clyde | University of Glasgow Dept of Anaesthesia | University of Glasgow, United Kingdom | Western Infirmary, Glasgow | West of Scotland Beatson Cancer Centre, Glasgow | Yorkhill Hospital, Glasgow, Scotland
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1992Last known activity
Aug 18, 2025
Timeline
1450s
- Jan 1, 1451
University of Glasgow— Founded
Drugs by trial phase (212 distinct, 168 trials)
Phase 4 (38 own, 0 via acquisition)
Phase 3 (67 own, 0 via acquisition)
Phase 2 (52 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Other trials (43 own, 0 via acquisition)
Indications
Studied for
- Acidosis
- Acidosis, Lactic
- Adenocarcinoma
- Adenocarcinoma, Clear Cell
- Adenomyoepithelioma
- Anemia, Iron-Deficiency
- Angina Pectoris
- Angina, Stable
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- Antithrombin III Deficiency
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Atherosclerosis
- Atrial Fibrillation
- Autism Spectrum Disorder
- Basal Cell Carcinoma
- Beriberi
- Brain Diseases
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Transitional Cell
- Cardiovascular Diseases
- Carotid Artery Diseases
- Central Nervous System Neoplasms
- Cerebral Infarction
- Chronic Periodontitis
- Colonic Neoplasms
- Coronary Artery Disease
- Crohn Disease
- Dementia, Vascular
- Dental Caries
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diabetic Retinopathy
- Endometrial Neoplasms
- Fallopian Tube Neoplasms
- Femoral Neck Fractures
- Glioblastoma
- Glioma
- Glucose Intolerance
- Glucose Metabolism Disorders
- Granulomatosis with Polyangiitis
- Guillain-Barre Syndrome
- Heart Diseases
- Heart Failure
- Hemorrhage
- Hyperglycemia
- Hypersensitivity
- Hypertension
- Hypertrophy
- Hypertrophy, Left Ventricular
- Hypogonadism
- Hypothyroidism
- Infarction
- Inflammation
- Inflammatory Breast Neoplasms
- Insulin Resistance
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Kidney Neoplasms
- Korsakoff Syndrome
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Magnesium Deficiency
- Melanoma
- Mesothelioma
- Metabolic Diseases
- Metabolic Syndrome
- Multiple Myeloma
- Multiple Sclerosis
- Myocardial Infarction
- Myocardial Ischemia
- Myocarditis
- Neoplasms
- Neoplasms, Plasma Cell
- Nervous System Neoplasms
- Neuralgia
- Neuroblastoma
- Osteoarthritis
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Papilloma
- Paralysis
- Paresis
- Parkinson Disease
- Periodontitis
- Plasmacytoma
Recent trials (50)
- NCT07130513Lead sponsorN/AAug 18, 2025
- NCT07130513Sponsor investigatorN/AAug 18, 2025
- NCT06821347CollaboratorPhase 2May 1, 2025
- NCT06821347Lead sponsorPhase 2May 1, 2025
- NCT06939244Lead sponsorN/AFeb 1, 2025
- NCT06939244Sponsor investigatorN/AFeb 1, 2025
- NCT06296875Sponsor investigatorN/AJul 31, 2024
- NCT06296875Lead sponsorN/AJul 31, 2024
- NCT06498518OfficialPhase 2Jun 17, 2024
- NCT06498518Lead sponsorPhase 2Jun 17, 2024
- NCT06498518CollaboratorPhase 2Jun 17, 2024
- NCT06498518Sponsor investigatorPhase 2Jun 17, 2024
- NCT06498518CollaboratorPhase 2Jun 17, 2024
- NCT06005064Reponsible party - principal investigatorN/ANov 1, 2023
- NCT06005064Lead sponsorN/ANov 1, 2023
Details
- Founded
- Glasgow, GB Jan 1, 1451
- Last known activity
- Aug 18, 2025